Ascentage Pharma Files 6-K for March 2025
Ticker: AAPG · Form: 6-K · Filed: Mar 27, 2025 · CIK: 2023311
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Ascentage Pharma (ASC) filed a 6-K on 3/27, standard reporting for foreign issuers.
AI Summary
Ascentage Pharma Group International filed a Form 6-K on March 27, 2025, reporting information for the month of March 2025. The filing is from their principal executive offices located at 68 Xinqing Road, Suzhou Industrial Park, Suzhou, Jiangsu, China. The company is a foreign private issuer and will file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for foreign private issuers, indicating ongoing compliance and reporting activities for Ascentage Pharma Group International.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- ASCENTAGE PHARMA GROUP INTERNATIONAL (company) — Filer of the report
- 68 Xinqing Road Suzhou Industrial Park Suzhou, Jiangsu China (location) — Principal executive offices
- March 2025 (date) — Reporting period
- Form 20-F (document) — Annual report form
- Form 6-K (document) — Type of filing
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide certain information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
What is the filing date of this 6-K report?
The filing date of this 6-K report is March 27, 2025.
Where are Ascentage Pharma Group International's principal executive offices located?
Ascentage Pharma Group International's principal executive offices are located at 68 Xinqing Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Does Ascentage Pharma Group International file annual reports under Form 20-F or Form 40-F?
Ascentage Pharma Group International indicates it files annual reports under Form 20-F.
What is the Commission File Number for this filing?
The Commission File Number for this filing is 001-42484.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 27, 2025 regarding ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).